Cherepanov P, Esté J A, Rando R F, Ojwang J O, Reekmans G, Steinfeld R, David G, De Clercq E, Debyser Z
Rega Institute for Medical Research, Katholieke Universiteit Leuven, B-3000 Leuven, Belgium.
Mol Pharmacol. 1997 Nov;52(5):771-80. doi: 10.1124/mol.52.5.771.
Oligonucleotides that can form a highly stable intramolecular four-stranded DNA structure containing two stacked guanosine-quartets (G-quartets) have been reported to inhibit the replication of the human immunodeficiency virus type 1 (HIV-1) in cell culture. Two possible mechanisms for the observed antiviral activity have been proposed: interference with virus adsorption to the cell and/or inhibition of HIV-1 integrase. We investigated the molecular interaction of G-quartet-containing oligonucleotides with HIV-1 integrase in comparison with random oligonucleotides and dextran sulfate. The prototypical G-quartet-containing oligonucleotide, T30177 (Zintevir), inhibited the overall integration reaction with an IC50 value of 80 nM. A random oligonucleotide was 10-fold less potent, but dextran sulfate was more potent, with an IC50 value of 7 nM. We developed novel kinetic assays to dissect the overall integration reaction in three steps: the formation of the initial stable complex (ISC), the 3'-processing reaction, and the DNA strand-transfer step. We then analyzed the kinetics of the ISC formation and 3'-processing. The rate constant determined for the conversion of ISC into the cleaved product was 0.08 +/- 0.01 min-1. T30177 did not inhibit 3'-processing or DNA strand transfer, whereas dextran sulfate inhibited DNA strand transfer to some extent. Binding studies using surface plasmon resonance technology revealed that both T30177 and dextran sulfate were capable of preventing the binding of integrase to specific DNA. We propose a model in which the interaction of HIV-1 integrase with G-quartets results in the inhibition of the formation of the ISC between integrase and substrate DNA. Finally, we selected for an HIV-1 strain that was resistant to T30177 in cell culture. DNA sequence analysis revealed mutations in the envelope glycoprotein gp120 but not in the integrase gene. Although gp120 seems to be the main target for the antiviral activity in cell culture of G-quartets, the study of their specific inhibition of HIV-1 integrase may lead to the development of effective integrase inhibitors.
据报道,能够形成包含两个堆叠鸟嘌呤四联体(G-四联体)的高度稳定分子内四链DNA结构的寡核苷酸,在细胞培养中可抑制1型人类免疫缺陷病毒(HIV-1)的复制。针对所观察到的抗病毒活性,已提出两种可能的机制:干扰病毒吸附到细胞上和/或抑制HIV-1整合酶。我们将含G-四联体的寡核苷酸与随机寡核苷酸和硫酸葡聚糖相比较,研究了它们与HIV-1整合酶的分子相互作用。典型的含G-四联体寡核苷酸T30177(Zintevir)抑制整体整合反应,IC50值为80 nM。一种随机寡核苷酸的效力低10倍,但硫酸葡聚糖效力更强,IC50值为7 nM。我们开发了新的动力学测定方法,将整体整合反应分解为三个步骤:初始稳定复合物(ISC)的形成、3'加工反应和DNA链转移步骤。然后我们分析了ISC形成和3'加工的动力学。确定的ISC转化为切割产物的速率常数为0.08±0.01 min-1。T30177不抑制3'加工或DNA链转移,而硫酸葡聚糖在一定程度上抑制DNA链转移。使用表面等离子体共振技术的结合研究表明,T30177和硫酸葡聚糖都能够阻止整合酶与特定DNA的结合。我们提出了一个模型,其中HIV-1整合酶与G-四联体的相互作用导致整合酶与底物DNA之间ISC形成的抑制。最后,我们在细胞培养中筛选出对T30177耐药的HIV-1毒株。DNA序列分析显示包膜糖蛋白gp120发生了突变,但整合酶基因未发生突变。虽然gp120似乎是细胞培养中G-四联体抗病毒活性的主要靶点,但对其对HIV-1整合酶的特异性抑制作用的研究可能会导致开发出有效的整合酶抑制剂。